200 related articles for article (PubMed ID: 34039707)
1. High Yap and Mll1 promote a persistent regenerative cell state induced by Notch signaling and loss of p53.
Heuberger J; Grinat J; Kosel F; Liu L; Kunz S; Vidal RO; Keil M; Haybaeck J; Robine S; Louvard D; Regenbrecht C; Sporbert A; Sauer S; von Eyss B; Sigal M; Birchmeier W
Proc Natl Acad Sci U S A; 2021 Jun; 118(22):. PubMed ID: 34039707
[TBL] [Abstract][Full Text] [Related]
2. The epigenetic regulator Mll1 is required for Wnt-driven intestinal tumorigenesis and cancer stemness.
Grinat J; Heuberger J; Vidal RO; Goveas N; Kosel F; Berenguer-Llergo A; Kranz A; Wulf-Goldenberg A; Behrens D; Melcher B; Sauer S; Vieth M; Batlle E; Stewart AF; Birchmeier W
Nat Commun; 2020 Dec; 11(1):6422. PubMed ID: 33349639
[TBL] [Abstract][Full Text] [Related]
3. The Histone Methyltransferase G9a Promotes Cholangiocarcinogenesis Through Regulation of the Hippo Pathway Kinase LATS2 and YAP Signaling Pathway.
Ma W; Han C; Zhang J; Song K; Chen W; Kwon H; Wu T
Hepatology; 2020 Oct; 72(4):1283-1297. PubMed ID: 31990985
[TBL] [Abstract][Full Text] [Related]
4. The histone methyltransferase MLL1 permits the oscillation of circadian gene expression.
Katada S; Sassone-Corsi P
Nat Struct Mol Biol; 2010 Dec; 17(12):1414-21. PubMed ID: 21113167
[TBL] [Abstract][Full Text] [Related]
5. Yes-associated protein up-regulates Jagged-1 and activates the Notch pathway in human hepatocellular carcinoma.
Tschaharganeh DF; Chen X; Latzko P; Malz M; Gaida MM; Felix K; Ladu S; Singer S; Pinna F; Gretz N; Sticht C; Tomasi ML; Delogu S; Evert M; Fan B; Ribback S; Jiang L; Brozzetti S; Bergmann F; Dombrowski F; Schirmacher P; Calvisi DF; Breuhahn K
Gastroenterology; 2013 Jun; 144(7):1530-1542.e12. PubMed ID: 23419361
[TBL] [Abstract][Full Text] [Related]
6. Targeting Epigenetic Crosstalk as a Therapeutic Strategy for EZH2-Aberrant Solid Tumors.
Huang X; Yan J; Zhang M; Wang Y; Chen Y; Fu X; Wei R; Zheng XL; Liu Z; Zhang X; Yang H; Hao B; Shen YY; Su Y; Cong X; Huang M; Tan M; Ding J; Geng M
Cell; 2018 Sep; 175(1):186-199.e19. PubMed ID: 30220457
[TBL] [Abstract][Full Text] [Related]
7. Yap-dependent reprogramming of Lgr5(+) stem cells drives intestinal regeneration and cancer.
Gregorieff A; Liu Y; Inanlou MR; Khomchuk Y; Wrana JL
Nature; 2015 Oct; 526(7575):715-8. PubMed ID: 26503053
[TBL] [Abstract][Full Text] [Related]
8. Reprogramming of the Epigenome by MLL1 Links Early-Life Environmental Exposures to Prostate Cancer Risk.
Wang Q; Trevino LS; Wong RL; Medvedovic M; Chen J; Ho SM; Shen J; Foulds CE; Coarfa C; O'Malley BW; Shilatifard A; Walker CL
Mol Endocrinol; 2016 Aug; 30(8):856-71. PubMed ID: 27219490
[TBL] [Abstract][Full Text] [Related]
9. MLL1 is essential for the senescence-associated secretory phenotype.
Capell BC; Drake AM; Zhu J; Shah PP; Dou Z; Dorsey J; Simola DF; Donahue G; Sammons M; Rai TS; Natale C; Ridky TW; Adams PD; Berger SL
Genes Dev; 2016 Feb; 30(3):321-36. PubMed ID: 26833731
[TBL] [Abstract][Full Text] [Related]
10. G9a stimulates CRC growth by inducing p53 Lys373 dimethylation-dependent activation of
Zhang J; Wang Y; Shen Y; He P; Ding J; Chen Y
Theranostics; 2018; 8(10):2884-2895. PubMed ID: 29774081
[No Abstract] [Full Text] [Related]
11. Physical association and coordinate function of the H3 K4 methyltransferase MLL1 and the H4 K16 acetyltransferase MOF.
Dou Y; Milne TA; Tackett AJ; Smith ER; Fukuda A; Wysocka J; Allis CD; Chait BT; Hess JL; Roeder RG
Cell; 2005 Jun; 121(6):873-85. PubMed ID: 15960975
[TBL] [Abstract][Full Text] [Related]
12. Somatic cancer mutations in the MLL1 histone methyltransferase modulate its enzymatic activity and dependence on the WDR5/RBBP5/ASH2L complex.
Weirich S; Kudithipudi S; Jeltsch A
Mol Oncol; 2017 Apr; 11(4):373-387. PubMed ID: 28182322
[TBL] [Abstract][Full Text] [Related]
13. Chromatin remodelling factor Mll1 is essential for neurogenesis from postnatal neural stem cells.
Lim DA; Huang YC; Swigut T; Mirick AL; Garcia-Verdugo JM; Wysocka J; Ernst P; Alvarez-Buylla A
Nature; 2009 Mar; 458(7237):529-33. PubMed ID: 19212323
[TBL] [Abstract][Full Text] [Related]
14. Amplified in breast cancer 1 promotes colorectal cancer progression through enhancing notch signaling.
Mo P; Zhou Q; Guan L; Wang Y; Wang W; Miao M; Tong Z; Li M; Majaz S; Liu Y; Su G; Xu J; Yu C
Oncogene; 2015 Jul; 34(30):3935-3945. PubMed ID: 25263446
[TBL] [Abstract][Full Text] [Related]
15. Automethylation activities within the mixed lineage leukemia-1 (MLL1) core complex reveal evidence supporting a "two-active site" model for multiple histone H3 lysine 4 methylation.
Patel A; Vought VE; Swatkoski S; Viggiano S; Howard B; Dharmarajan V; Monteith KE; Kupakuwana G; Namitz KE; Shinsky SA; Cotter RJ; Cosgrove MS
J Biol Chem; 2014 Jan; 289(2):868-84. PubMed ID: 24235145
[TBL] [Abstract][Full Text] [Related]
16. An Ash2L/RbBP5 heterodimer stimulates the MLL1 methyltransferase activity through coordinated substrate interactions with the MLL1 SET domain.
Cao F; Chen Y; Cierpicki T; Liu Y; Basrur V; Lei M; Dou Y
PLoS One; 2010 Nov; 5(11):e14102. PubMed ID: 21124902
[TBL] [Abstract][Full Text] [Related]
17. Neuronal Kmt2a/Mll1 histone methyltransferase is essential for prefrontal synaptic plasticity and working memory.
Jakovcevski M; Ruan H; Shen EY; Dincer A; Javidfar B; Ma Q; Peter CJ; Cheung I; Mitchell AC; Jiang Y; Lin CL; Pothula V; Stewart AF; Ernst P; Yao WD; Akbarian S
J Neurosci; 2015 Apr; 35(13):5097-108. PubMed ID: 25834037
[TBL] [Abstract][Full Text] [Related]
18. MLL2, Not MLL1, Plays a Major Role in Sustaining MLL-Rearranged Acute Myeloid Leukemia.
Chen Y; Anastassiadis K; Kranz A; Stewart AF; Arndt K; Waskow C; Yokoyama A; Jones K; Neff T; Lee Y; Ernst P
Cancer Cell; 2017 Jun; 31(6):755-770.e6. PubMed ID: 28609655
[TBL] [Abstract][Full Text] [Related]
19. Histone methylase MLL1 coordinates with HIF and regulate lncRNA HOTAIR expression under hypoxia.
Bhan A; Deb P; Shihabeddin N; Ansari KI; Brotto M; Mandal SS
Gene; 2017 Sep; 629():16-28. PubMed ID: 28756022
[TBL] [Abstract][Full Text] [Related]
20. Analysis of Mll1 deficiency identifies neurogenic transcriptional modules and Brn4 as a factor for direct astrocyte-to-neuron reprogramming.
Potts MB; Siu JJ; Price JD; Salinas RD; Cho MJ; Ramos AD; Hahn J; Margeta M; Oldham MC; Lim DA
Neurosurgery; 2014 Oct; 75(4):472-82; discussion 482. PubMed ID: 24887289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
